Bank of Montreal’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.41M Buy
9,700
+7,500
+341% +$2.67M ﹤0.01% 1465
2025
Q4
$720K Buy
+2,200
New +$698K ﹤0.01% 2144
2025
Q2
Sell
-50,000
Closed -$15.6M 3503
2025
Q1
$15.6M Buy
+50,000
New +$14.8M 0.01% 787
2024
Q1
Sell
-10,000
Closed -$2.89M 3855
2023
Q4
$2.89M Buy
10,000
+5,000
+100% +$1.36M ﹤0.01% 1515
2023
Q3
$1.31M Buy
+5,000
New +$1.25M ﹤0.01% 1917
2022
Q2
Sell
-5,000
Closed -$1.28M 4060
2022
Q1
$1.28M Buy
+5,000
New +$1.15M ﹤0.01% 2184
2021
Q2
Sell
-15,000
Closed -$3.7M 3677
2021
Q1
$3.7M Sell
15,000
-71,950
-83% -$17.2M ﹤0.01% 1493
2020
Q4
$20.7M Buy
+86,950
New +$20M 0.01% 697
2020
Q1
Sell
-19,000
Closed -$4.58M 4071
2019
Q4
$4.58M Buy
+19,000
New +$4.19M ﹤0.01% 1415
2019
Q2
Sell
-6,600
Closed -$1.25M 4840
2019
Q1
$1.25M Buy
6,600
+2,000
+43% +$382K ﹤0.01% 1929
2018
Q4
$895K Buy
+4,600
New +$897K ﹤0.01% 1935
2018
Q1
Sell
-500
Closed -$87K 4150
2017
Q4
$87K Sell
500
-92,300
-99% -$16.3M ﹤0.01% 3052
2017
Q3
$17.3M Buy
+92,800
New +$16.4M 0.02% 642

Other funds holding AMGN

Bank of Montreal's AMGN Position: Q1 2026 in Review

Bank of Montreal reduced its Amgen (AMGN) stake by 11% in Q1 2026, selling an estimated $43.7M and leaving 961,165 shares worth $338M. The position accounts for 0.13% of the portfolio, ranked #143.

Bank of Montreal first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $602M in Q2 2021. 3,137 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Bank of Montreal held 961,165 shares of Amgen worth $338M as of Q1 2026.
  • Bank of Montreal sold 122,655 Amgen shares in Q1 2026, an estimated $43.7M.
  • Amgen made up 0.13% of Bank of Montreal's portfolio in Q1 2026, its #143 holding.
  • Bank of Montreal first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • Bank of Montreal's Amgen position peaked at $602M in Q2 2021.
  • 3,137 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.